Shares of Cardinal Health, Inc. (NYSE:CAH – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen ratings firms that are currently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $158.0714.
CAH has been the topic of several research reports. Evercore ISI reaffirmed an “outperform” rating and issued a $180.00 price objective (up previously from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Citigroup reaffirmed a “neutral” rating and issued a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Robert W. Baird lifted their price objective on shares of Cardinal Health from $156.00 to $170.00 and gave the stock an “outperform” rating in a research report on Friday, May 2nd. Morgan Stanley lifted their price objective on shares of Cardinal Health from $181.00 to $190.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 16th. Finally, UBS Group lifted their price objective on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a “buy” rating in a research report on Tuesday, April 29th.
Read Our Latest Research Report on CAH
Hedge Funds Weigh In On Cardinal Health
Cardinal Health Price Performance
CAH opened at $157.44 on Friday. The firm has a market capitalization of $37.58 billion, a P/E ratio of 24.56, a PEG ratio of 1.56 and a beta of 0.67. Cardinal Health has a fifty-two week low of $98.07 and a fifty-two week high of $168.44. The company’s 50-day moving average is $160.05 and its 200 day moving average is $143.86.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
- Five stocks we like better than Cardinal Health
- How to Invest in the FAANG Stocks
- Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact?
- Industrial Products Stocks Investing
- Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Now Is a Great Time to Buy Cheniere Energy: New High Expected
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.